11 Results for "

prostaglandin E2 receptor EP1

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "prostaglandin E2 receptor EP1" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-128686
CAS No.: 1215192-68-9
Purity:  98.62%
KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-α production. KAG-308 shows a Ki and an EC50 of 2.57 nM and 17 nM for human EP4 receptor, respectively, more selective over EP1, EP2, EP3 and IP receptor .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108563
CAS No.: 146033-02-5
Research Areas:  

Neurological Disease

SC 51089 is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 exhibits neuroprotective activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108563A
CAS No.: 146033-03-6
Purity:  98.64%
Research Areas:  

Neurological Disease

SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity .
loading...
    loading...
Cat. No.: HY-14467
CAS No.: 892664-04-9
Purity:  99.74%
GSK-269984A is a Prostaglandin E2 Receptor 1 (EP1) antagonist with a pIC50 of 7.9.
loading...
    loading...
Cat. No.: HY-102065
CAS No.: 19395-87-0
Purity:  99.71%
Research Areas:  

Metabolic Disease

SC-19220 is a prostaglandin E2 receptor EP1 antagonist. SC-19220 blocks functional EP1 receptor activation, and RANK/RANKL signaling pathway. SC-19220 inhibits osteoclast formation and bone resorption by pre-existing osteoclasts. SC-19220 can be used for the research of osteoporotic disorders, inflammatory bone resorption .
loading...
    loading...
Cat. No.: HY-108562
CAS No.: 146032-79-3
Purity:  98.9%
Research Areas:  

Neurological Disease

SC-51322 is a potent and selective antagonist of prostaglandin E2 (PGE2) receptor (EP 1), with a pA2 of 8.1. SC-51322 has the pain-relieving effect .
loading...
    loading...
Cat. No.: HY-106054
CAS No.: 79360-43-3
Nocloprost, a prostaglandin E2 (PGE2) analog, is an orally active EP1- and EP3-receptor agonist. Nocloprost inhibits evoked [ 3H]ACh release. Nocloprost has gastroprotective and ulcer-healing properties. Nocloprost accelerates the healing of chronic gastric ulcerations and enhances mucosal growth in rats .
loading...
    loading...
Cat. No.: HY-138868
CAS No.: 1219032-20-8
Synonyms: 17-Phenyl trinor PGE2 ethyl amide
Research Areas:  

Metabolic Disease

17-Phenyl trinor prostaglandin E2 ethyl amide (17-Phenyl trinor PGE2 ethyl amide) is a EP1 receptor agonist. 17-Phenyl trinor prostaglandin E2 ethyl amide aggravates renal dysfunction and glomerulosclerosis .
loading...
    loading...
Cat. No.: HY-179901
CAS No.: 155205-99-5
Target:  

Others

Research Areas:  

Endocrinology

17-phenyl trinor Prostaglandin F2α isopropyl amide is a derivative of 17-phenyl trinor prostaglandin F2α ethyl amide.17-Phenyl trinor prostaglandin E2 ethyl amide (17-Phenyl trinor PGE2 ethyl amide) is a EP1 receptor agonist. 17-Phenyl trinor prostaglandin E2 ethyl amide aggravates renal dysfunction and glomerulosclerosis.
loading...
    loading...
Cat. No.: HY-108563AR
CAS No.: 146033-03-6
SC 51089 free base (Standard) is the analytical standard of SC 51089 (free base) (HY-108563A). This product is intended for research and analytical applications. SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity .
loading...
    loading...
Cat. No.: HY-102065R
CAS No.: 19395-87-0
SC-19220 (Standard) is the analytical standard of SC-19220 (HY-102065). This product is intended for research and analytical applications. SC-19220 is a prostaglandin E2 receptor EP1 antagonist. SC-19220 blocks functional EP1 receptor activation, and RANK/RANKL signaling pathway. SC-19220 inhibits osteoclast formation and bone resorption by pre-existing osteoclasts. SC-19220 can be used for the research of osteoporotic disorders, inflammatory bone resorption .
loading...
    loading...
  • 1